167 related articles for article (PubMed ID: 11857366)
1. Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
Engebraaten O; Hjortland GO; Juell S; Hirschberg H; Fodstad O
Int J Cancer; 2002 Feb; 97(6):846-52. PubMed ID: 11857366
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
Hjortland GO; Garman-Vik SS; Juell S; Olsen OE; Hirschberg H; Fodstad O; Engebraaten O
J Neurosurg; 2004 Feb; 100(2):320-7. PubMed ID: 15086240
[TBL] [Abstract][Full Text] [Related]
3. Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara N; Walbridge S; Olson AW; Oldfield EH; Youle RJ
Cancer Res; 2000 Jan; 60(2):230-4. PubMed ID: 10667564
[TBL] [Abstract][Full Text] [Related]
4. Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
Archer GE; Sampson JH; Lorimer IA; McLendon RE; Kuan CT; Friedman AH; Friedman HS; Pastan IH; Bigner DD
Clin Cancer Res; 1999 Sep; 5(9):2646-52. PubMed ID: 10499644
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
6. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
Engebraaten O; Sivam G; Juell S; Fodstad O
Int J Cancer; 2000 Dec; 88(6):970-6. PubMed ID: 11093823
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
Myklebust AT; Godal A; Fodstad O
Cancer Res; 1994 Apr; 54(8):2146-50. PubMed ID: 8174121
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme.
Hall WA; Godal A; Juell S; Fodstad O
J Neurosurg; 1992 May; 76(5):838-44. PubMed ID: 1314294
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Hall WA; Myklebust A; Godal A; Nesland JM; Fodstad O
Neurosurgery; 1994 Apr; 34(4):649-55; discussion 655-6. PubMed ID: 8008162
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
[TBL] [Abstract][Full Text] [Related]
12. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.
Reiter Y; Brinkmann U; Jung SH; Lee B; Kasprzyk PG; King CR; Pastan I
J Biol Chem; 1994 Jul; 269(28):18327-31. PubMed ID: 7913461
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
Pearson JW; FitzGerald DJ; Willingham MC; Wiltrout RH; Pastan I; Longo DL
Cancer Res; 1989 Jul; 49(13):3562-7. PubMed ID: 2499420
[TBL] [Abstract][Full Text] [Related]
14. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.
Puri RK
Methods Mol Biol; 2001; 166():155-76. PubMed ID: 11217365
[No Abstract] [Full Text] [Related]
16. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.
Nagai T; Tanaka M; Tsuneyoshi Y; Xu B; Michie SA; Hasui K; Hirano H; Arita K; Matsuyama T
Cancer Immunol Immunother; 2009 Oct; 58(10):1577-86. PubMed ID: 19238383
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255
[TBL] [Abstract][Full Text] [Related]
18. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
Reiter Y; Wright AF; Tonge DW; Pastan I
Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
[TBL] [Abstract][Full Text] [Related]
19. HER2-targeted immunotoxins with low nonspecific toxicity and immunogenicity.
Guo R; Cao L; Guo W; Liu H; Xu H; Fang Q; Hong Z
Biochem Biophys Res Commun; 2016 Jun; 475(1):93-9. PubMed ID: 27178207
[TBL] [Abstract][Full Text] [Related]
20. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice.
Benhar I; Pastan I
Clin Cancer Res; 1995 Sep; 1(9):1023-9. PubMed ID: 9816075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]